The United States Food and Drug Administration recently approved Uplizna ® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) among adults who are antiacetylcholine receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results